ARIBIO
ARIBIO
Social Links:
Industry:
Artificial Intelligence (AI) Biotechnology Medical
Founded:
2010-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.aribio.com
Total Employee:
51+
Status:
Active
Contact:
02-2637-0009,
Total Funding:
100 B KRW
Technology used in webpage:
Google Font API ReCAPTCHA GStatic Google Static Content CrUX Dataset YouTube ReCAPTCHA V2 CrUX Top 10m Apache 2.4 COVID-19 Ubuntu
Similar Organizations
BrightGene
BrightGene is a biopharma company.
BRIM Biotechnology
BRIM Biotechnology is a pharmaceutical company.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Sweetch
Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions.
Current Employees Featured
Investors List
Milestone
Milestone investment in Venture Round - AriBio
Lambda Asset Management
Lambda Asset Management investment in Venture Round - AriBio
Meritz Securities
Meritz Securities investment in Venture Round - AriBio
Official Site Inspections
http://www.aribio.com Semrush global rank: 11.73 M Semrush visits lastest month: 149
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AriBio"
AriBio
AriBio Co., Ltd. is a biotechnology leader focused on creating impactful therapies for neurodegenerative diseases. Through our groundbreaking ARIDD™ platform (AI-powered, Reverse engineered & Integrated Drug Development) and a …See details»
AriBio
AriBio Receives IND Approval from China’s NMPA for POLARIS-AD, a Phase... 2024.05.20 [Apr 28, 2024]AriBio Receives EMA Phase 3 Clinical Trial Authorisation...See details»
AriBio - Crunchbase Company Profile & Funding
Organization. AriBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AriBio is a pharmaceutical company. Seongnam, …See details»
ARIBIO Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ARIBIO Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 17 news, and 13 literature, Disease Domain:Nervous System Diseases, Endocrinology …See details»
ARIBIO CO., Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARIBIO CO., Ltd. of Seongnam, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»
AriBio Overview | SignalHire Company Profile
AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. ... Organization Website. …See details»
AriBio Company Profile 2024: Valuation, Funding
AriBio General Information Description. Developer of novel therapeutics focused on the treatment of neurodegenerative and infectious diseases. The company engages in drug development for Alzheimer's disease, sepsis and obesity …See details»
AriBio - LinkedIn
AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases.See details»
AriBio
December 22, 2023 06:33 PM Eastern Standard Time At AriBio, our commitment to pioneering new therapies for neurodegenerative diseases is at the heart of everything we do. We're …See details»
ARIBIO - Overview, News & Similar companies | ZoomInfo.com
Mar 24, 2024 AriBio Receives IND Approval from China’s NMPA for POLARIS-AD, a Phase 3 Trial for the Treatment of Early Alzheimer’s Disease SEONGNAM-SI, South Korea- …See details»
AriBio - Products, Competitors, Financials, Employees, …
AriBio. Frequently Asked Questions (FAQ) When was AriBio founded? AriBio was founded in 2010. Where is AriBio's headquarters? AriBio's headquarters is located at 56 Dongpangyo-ro, …See details»
AriBio Financial Overview, Employee Count, and Competitors
AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. The US office is located in San …See details»
Aribio Usa - Overview, News & Similar companies | ZoomInfo.com
AriBio Co., Ltd. is a biopharmaceutical company based in South Korea with a focus on neurodegenerative and infectious diseases. AR1003 is the lead candidate for sepsis and …See details»
AriBio USA, INC. Information - RocketReach
AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. The US office is located in San …See details»
AriBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Money Raised . Lead Investors . Feb 18, 2022: Venture Round - AriBio . …See details»
AriBio
AriBio completed a Phase 2 study in 2021 in mild to moderate Alzheimer’s disease patients with their lead compound AR1001, a PDE5 inhibitor with preclinical efficacy shown to inhibit neuron …See details»
ARIBIO - Company Profile - Tracxn
Oct 22, 2024 ARIBIO - Developer of therapeutics to treat multiple diseases. ARIBIO has 647 competitors.See details»
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Milestone ...
Jul 16, 2024 AriBio Co., Ltd. is a biopharmaceutical company based in South Korea with offices in the United States. The company focuses on the development of novel therapies for …See details»
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Milestone ...
Jul 16, 2024 San Diego, CA, Tokyo, Japan and Malvern, PA-- (BUSINESS WIRE), July 12 th, 2024 – Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and …See details»
AriBio
To address this complexity, AriBio’s Platform Research Center has developed ARIS: a proprietary AI platform optimized for predicting these multifaceted biological interrelationships, thus …See details»